Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function.

Thomas L, Xue J, Murali SK, Fenton RA, Dominguez Rieg JA, Rieg T.

J Am Soc Nephrol. 2019 Aug 13. pii: ASN.2018121250. doi: 10.1681/ASN.2018121250. [Epub ahead of print]

PMID:
31409727
2.

Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter.

Cheng L, Poulsen SB, Wu Q, Esteva-Font C, Olesen ETB, Peng L, Olde B, Leeb-Lundberg LMF, Pisitkun T, Rieg T, Dimke H, Fenton RA.

J Am Soc Nephrol. 2019 Aug;30(8):1454-1470. doi: 10.1681/ASN.2018101025. Epub 2019 Jun 28.

PMID:
31253651
3.

What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.

Dominguez Rieg JA, Rieg T.

Diabetes Obes Metab. 2019 Apr;21 Suppl 2:43-52. doi: 10.1111/dom.13630.

PMID:
31081587
4.

Risk factors for abdominal wall defects.

Kapapa M, Rieg T, Henne-Bruns D, Serra A.

Congenit Anom (Kyoto). 2019 Apr 1. doi: 10.1111/cga.12336. [Epub ahead of print]

PMID:
30932237
5.

Adenylyl cyclase 6 expression is essential for cholera toxin-induced diarrhea.

Fenton RA, Murali SK, Kaji I, Akiba Y, Kaunitz JD, Kristensen TB, Poulsen SB, Dominguez Rieg JA, Rieg T.

J Infect Dis. 2019 Jan 8. doi: 10.1093/infdis/jiz013. [Epub ahead of print]

PMID:
30624615
6.

Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics.

Thomas L, Xue J, Dominguez Rieg JA, Rieg T.

Eur J Pharm Sci. 2019 Feb 1;128:1-7. doi: 10.1016/j.ejps.2018.11.008. Epub 2018 Nov 9.

PMID:
30419292
7.

Development of SGLT1 and SGLT2 inhibitors.

Rieg T, Vallon V.

Diabetologia. 2018 Oct;61(10):2079-2086. doi: 10.1007/s00125-018-4654-7. Epub 2018 Aug 22. Review.

PMID:
30132033
8.

Adenylyl cyclase 6 is required for maintaining acid-base homeostasis.

Poulsen SB, Marin De Evsikova C, Murali SK, Praetorius J, Chern Y, Fenton RA, Rieg T.

Clin Sci (Lond). 2018 Aug 30;132(16):1779-1796. doi: 10.1042/CS20180060. Print 2018 Aug 31.

PMID:
29941522
9.

Holding tight and staying true: generation of a new tamoxifen-inducible, principal cell-specific mouse.

Dominguez Rieg JA, Rieg T.

Am J Physiol Renal Physiol. 2018 May 1;314(5):F932-F933. doi: 10.1152/ajprenal.00005.2018. Epub 2018 Jan 10. No abstract available.

10.

Body mass-specific Na+-K+-ATPase activity in the medullary thick ascending limb: implications for species-dependent urine concentrating mechanisms.

Aw M, Armstrong TM, Nawata CM, Bodine SN, Oh JJ, Wei G, Evans KK, Shahidullah M, Rieg T, Pannabecker TL.

Am J Physiol Regul Integr Comp Physiol. 2018 Apr 1;314(4):R563-R573. doi: 10.1152/ajpregu.00289.2017. Epub 2018 Jan 3. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2019 Jun 1;316(6):R726.

11.

Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.

Poulsen SB, Kristensen TB, Brooks HL, Kohan DE, Rieg T, Fenton RA.

JCI Insight. 2017 Apr 6;2(7):e91042. doi: 10.1172/jci.insight.91042.

12.

Renal tubular NHE3 is required in the maintenance of water and sodium chloride homeostasis.

Fenton RA, Poulsen SB, de la Mora Chavez S, Soleimani M, Dominguez Rieg JA, Rieg T.

Kidney Int. 2017 Aug;92(2):397-414. doi: 10.1016/j.kint.2017.02.001. Epub 2017 Apr 3.

13.

Reply to "Reduced NHE3 activity results in congenital diarrhea and can predispose to inflammatory bowel disease".

Rieg T, Dominguez Rieg JA.

Am J Physiol Regul Integr Comp Physiol. 2017 Mar 1;312(3):R312. doi: 10.1152/ajpregu.00550.2016. No abstract available.

14.

Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3.

Dominguez Rieg JA, de la Mora Chavez S, Rieg T.

Am J Physiol Regul Integr Comp Physiol. 2016 Dec 1;311(6):R1186-R1191. doi: 10.1152/ajpregu.00372.2016. Epub 2016 Oct 12. Review.

15.

Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models.

Mir SA, Zhang K, Milic M, Gu Y, Rieg T, Ziegler M, Vaingankar SM.

J Hypertens. 2016 Jan;34(1):68-78. doi: 10.1097/HJH.0000000000000760.

16.

Regulation of intestinal SGLT1 by catestatin in hyperleptinemic type 2 diabetic mice.

Dominguez Rieg JA, Chirasani VR, Koepsell H, Senapati S, Mahata SK, Rieg T.

Lab Invest. 2016 Jan;96(1):98-111. doi: 10.1038/labinvest.2015.129. Epub 2015 Nov 9.

17.

Sodium-glucose cotransport.

Poulsen SB, Fenton RA, Rieg T.

Curr Opin Nephrol Hypertens. 2015 Sep;24(5):463-9. doi: 10.1097/MNH.0000000000000152. Review.

18.

Caffeine-induced diuresis and natriuresis is independent of renal tubular NHE3.

Fenton RA, Poulsen SB, de la Mora Chavez S, Soleimani M, Busslinger M, Dominguez Rieg JA, Rieg T.

Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1409-20. doi: 10.1152/ajprenal.00129.2015. Epub 2015 Apr 29.

19.

P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.

Dominguez Rieg JA, Burt JM, Ruth P, Rieg T.

Acta Physiol (Oxf). 2015 Mar;213(3):628-41. doi: 10.1111/apha.12446. Epub 2015 Jan 8.

20.

Renal phosphate wasting in the absence of adenylyl cyclase 6.

Fenton RA, Murray F, Dominguez Rieg JA, Tang T, Levi M, Rieg T.

J Am Soc Nephrol. 2014 Dec;25(12):2822-34. doi: 10.1681/ASN.2013101102. Epub 2014 May 22.

21.

Regulation of nephron water and electrolyte transport by adenylyl cyclases.

Rieg T, Kohan DE.

Am J Physiol Renal Physiol. 2014 Apr 1;306(7):F701-9. doi: 10.1152/ajprenal.00656.2013. Epub 2014 Jan 29. Review.

22.

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.

Vallon V, Gerasimova M, Rose MA, Masuda T, Satriano J, Mayoux E, Koepsell H, Thomson SC, Rieg T.

Am J Physiol Renal Physiol. 2014 Jan;306(2):F194-204. doi: 10.1152/ajprenal.00520.2013. Epub 2013 Nov 13.

23.

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.

Rieg T, Masuda T, Gerasimova M, Mayoux E, Platt K, Powell DR, Thomson SC, Koepsell H, Vallon V.

Am J Physiol Renal Physiol. 2014 Jan;306(2):F188-93. doi: 10.1152/ajprenal.00518.2013. Epub 2013 Nov 13.

24.

Connecting type A intercalated cell metabolic state to V-ATPase function: phosphorylation does matter!

Rieg T, Dominguez Rieg J.

Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1105-6. doi: 10.1152/ajprenal.00428.2013. Epub 2013 Jul 31. No abstract available.

25.
26.

Serotonin reuptake inhibitors and bleeding risks in major orthopedic procedures.

Tavakoli HR, DeMaio M, Wingert NC, Rieg TS, Cohn JA, Balmer RP, Dillard MA.

Psychosomatics. 2012 Nov-Dec;53(6):559-65. doi: 10.1016/j.psym.2012.05.001.

PMID:
23157994
27.

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T.

Am J Physiol Renal Physiol. 2013 Jan 15;304(2):F156-67. doi: 10.1152/ajprenal.00409.2012. Epub 2012 Nov 14.

28.

P2Y receptors and kidney function.

Vallon V, Stockand J, Rieg T.

Wiley Interdiscip Rev Membr Transp Signal. 2012;1(6):731-742. Epub 2012 Aug 9.

29.

Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC.

Rieg T, Tang T, Uchida S, Hammond HK, Fenton RA, Vallon V.

Am J Pathol. 2013 Jan;182(1):96-106. doi: 10.1016/j.ajpath.2012.09.014. Epub 2012 Nov 1.

30.

Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.

Rieg T, Gerasimova M, Murray F, Masuda T, Tang T, Rose M, Drucker DJ, Vallon V.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F963-71. doi: 10.1152/ajprenal.00259.2012. Epub 2012 Jul 25.

31.

A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.

Vallon V, Eraly SA, Rao SR, Gerasimova M, Rose M, Nagle M, Anzai N, Smith T, Sharma K, Nigam SK, Rieg T.

Am J Physiol Renal Physiol. 2012 May 15;302(10):F1293-9. doi: 10.1152/ajprenal.00013.2012. Epub 2012 Feb 15.

32.

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.

Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H.

Diabetes. 2012 Jan;61(1):187-96. doi: 10.2337/db11-1029. Epub 2011 Nov 28.

33.

Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat.

Thomson SC, Rieg T, Miracle C, Mansoury H, Whaley J, Vallon V, Singh P.

Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R75-83. doi: 10.1152/ajpregu.00357.2011. Epub 2011 Sep 21.

34.

Postpartum insertion of levonorgestrel--intrauterine system at three time periods: a prospective randomized pilot study.

Dahlke JD, Terpstra ER, Ramseyer AM, Busch JM, Rieg T, Magann EF.

Contraception. 2011 Sep;84(3):244-8. doi: 10.1016/j.contraception.2011.01.007. Epub 2011 Feb 24.

PMID:
21843688
35.

Regulation of renal NaCl and water transport by the ATP/UTP/P2Y2 receptor system.

Vallon V, Rieg T.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F463-75. doi: 10.1152/ajprenal.00236.2011. Epub 2011 Jun 29. Review.

36.

Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS, Balijepalli RC, Murray F, Head BP, Niesman IR, Rieg T, Vallon V, Insel PA, Patel HH, Roth DM.

J Am Coll Cardiol. 2011 May 31;57(22):2273-83. doi: 10.1016/j.jacc.2010.12.032.

37.

P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Rieg T, Gerasimova M, Boyer JL, Insel PA, Vallon V.

Am J Physiol Regul Integr Comp Physiol. 2011 Aug;301(2):R510-8. doi: 10.1152/ajpregu.00148.2011. Epub 2011 May 25.

38.

Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.

Sweeney DE, Vallon V, Rieg T, Wu W, Gallegos TF, Nigam SK.

Mol Pharmacol. 2011 Jul;80(1):147-54. doi: 10.1124/mol.110.070680. Epub 2011 Apr 14.

39.

Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade.

Deng A, Arndt MA, Satriano J, Singh P, Rieg T, Thomson S, Tang T, Blantz RC.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1365-73. doi: 10.1152/ajprenal.00153.2010. Epub 2010 Sep 29.

40.

Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.

Rieg T, Tang T, Murray F, Schroth J, Insel PA, Fenton RA, Hammond HK, Vallon V.

J Am Soc Nephrol. 2010 Dec;21(12):2059-68. doi: 10.1681/ASN.2010040409. Epub 2010 Sep 23.

41.

Purinergic inhibition of ENaC produces aldosterone escape.

Stockand JD, Mironova E, Bugaj V, Rieg T, Insel PA, Vallon V, Peti-Peterdi J, Pochynyuk O.

J Am Soc Nephrol. 2010 Nov;21(11):1903-11. doi: 10.1681/ASN.2010040377. Epub 2010 Sep 2.

42.

SGLT2 mediates glucose reabsorption in the early proximal tubule.

Vallon V, Platt KA, Cunard R, Schroth J, Whaley J, Thomson SC, Koepsell H, Rieg T.

J Am Soc Nephrol. 2011 Jan;22(1):104-12. doi: 10.1681/ASN.2010030246. Epub 2010 Jul 8.

43.

Corneal abrasions in young infants.

Shope TR, Rieg TS, Kathiria NN.

Pediatrics. 2010 Mar;125(3):e565-9. doi: 10.1542/peds.2008-2023. Epub 2010 Feb 8.

PMID:
20142290
44.

Dietary Na+ inhibits the open probability of the epithelial sodium channel in the kidney by enhancing apical P2Y2-receptor tone.

Pochynyuk O, Rieg T, Bugaj V, Schroth J, Fridman A, Boss GR, Insel PA, Stockand JD, Vallon V.

FASEB J. 2010 Jun;24(6):2056-65. doi: 10.1096/fj.09-151506. Epub 2010 Jan 22.

45.

A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.

Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT.

Ann Emerg Med. 2010 Jul;56(1):1-6. doi: 10.1016/j.annemergmed.2009.11.020. Epub 2010 Jan 4.

PMID:
20045576
46.

Unravelling a role for KCNQ1 in K+ recycling and gastric acid secretion.

Rieg T, Dominguez JA.

J Physiol. 2009 Sep 1;587(Pt 17):4149-50. doi: 10.1113/jphysiol.2009.178103. No abstract available.

47.

Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function.

Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera DR, Ross RS, Nigam SK.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F210-7. doi: 10.1152/ajprenal.90260.2008. Epub 2009 May 13.

48.

Reduction of conscious sedation requirements by olfactory stimulation: a prospective randomized single-blinded trial.

Puttler K, Jaklic B, Rieg TS, Lucha PA Jr.

J Altern Complement Med. 2009 Apr;15(4):381-5. doi: 10.1089/acm.2008.0257.

PMID:
19388860
49.

Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus.

Vallon V, Schroth J, Satriano J, Blantz RC, Thomson SC, Rieg T.

Nephron Physiol. 2009;111(3):p30-8. doi: 10.1159/000208211. Epub 2009 Mar 10.

50.

The impact of pregnancy on the individual and military organization: a postpartum active duty survey.

Biggs RL, Douglas BH, O'Boyle AL, Rieg TS.

Mil Med. 2009 Jan;174(1):61-75.

PMID:
19216300

Supplemental Content

Support Center